Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir DF versus adefovir for presumed pre-core mutant chronic hepatitis B
2004-005119-27Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Chronic Hepatitis B (CHB) comparing Viread arm with Hepsera arm (2 arms). Primary endpoint: Complete response at end of double-blind treatment period. Started Mar 2005; status: completed.
02
Drugs
tenofovir disoproxil fumarateadefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2004-005119-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005119-27.